Boston Scientific (BSX) Q4 'Rock Solid', BofA/Merrill Lynch Says; Likes Risk/Reward Ahead of Ruling

February 4, 2015 12:03 PM

BofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and raised his price target on Boston Scientific (NYSE: BSX) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found